Adial Pharmaceuticals Targets $40B Addiction Market
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
- Latest
- Trending
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
The U.S. opioid crisis necessitates a strategic approach to allocating settlement funds for health IT infrastructure. Three recommendations include integrating ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.